GSK's Curbs On Parallel Trading May Be Illegal: Court

Law360 (September 16, 2008, 12:00 AM EDT) -- A GlaxoSmithKline PLC subsidiary's practice of selling three drugs in Greece on a quota system in order to combat parallel trading may constitute a violation of competition laws, Europe's highest court said Tuesday.

The ruling by the European Court of Justice, which holds that a pharmaceutical company is abusing its dominant position if it refuses to meet “ordinary” orders by wholesalers in order to prevent parallel exports, comes in a long-running court battle Glaxo subsidiary GlaxoSmithKline AEVE has been facing over the practice.

Whether Glaxo's orders...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.